A phase II study to demonstrate the efficacy of GC021109 in patients with Alzheimer's disease .
Phase of Trial: Phase II
Latest Information Update: 16 Dec 2015
At a glance
- Drugs GC 021109 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 16 Dec 2015 New trial record